michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I think -- so when you look at the impact of the change in the calendar year-over-year, it's beneficial to the way we look at ECS because so much of that business is calendar quarter end dependent. So, in Q1, we pick up a calendar quarter-end and what happened last year is, Q4 was really the big quarter. So, I think you're going to see a Q1, Q4 shift year-on-year where Q1 will be relatively stronger. And the offset will take place in Q4.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's digital and technology for sure and even finance and accounting. So it's probably what you would expect, we're seeing an incredible appetite in the world to get people that are digitally savvy, that are technology enabled and so we've seen very, very good drivers there. But the business quite candidly is just woefully undersized to the market opportunity and that's a pretty, so that's kind of a blanket statement. I mean, whether it's in the Americas or Asia or Europe, I think we've got a substantial runway ahead of us and that runway again, it's not in a few months, it's not a quarter out, but here in the very near term. I think you'll see us seizing on that market.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So I think as I see and when we're looking at the B2B business, we are seeing -- yes, sequentially, active accounts might be down a little bit, but year-to-year, they're up. So we do look in terms of a key metric for us in that segment, we do look at active accounts, yes, and -- but also the total GDV in that segment is also a real important indicator. We had the Money20/20 conference last week, and I met with a number of our partners in that business, and I came away more enthusiastic than ever. about the path we're on in terms of kind of embedding ourselves as the digital payments financial service provider to many of these key partners, some really exciting things on the horizon, I believe.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, David. This is Dan again. Maybe I'll start and then turn it over to Frank on the loss ratio. On operating loss overall, we were pleased to report this quarter that we're expecting to close the year on the favorable side of the midpoint of our original operating loss guidance.
And that is a function of the execution that we've been undertaking and the dip in performance marketing spend that we highlighted during the quarter. And I think it's fair to say that we expect to deliver a meaningful improvement in full year operating loss in 2022 versus the 2021 levels as we continue with that strategy and continue with that focused and disciplined execution. As for the loss ratio, I'll turn it over to Frank to speak to trends he's seeing next year.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, Damian.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I mean I think that's very specific guidance. I'm not sure we gave the $300 million to 350 million. But we did say, look, we are at activity levels that were consistent with pre-pandemic. And so you can take a look at kind of where we were there a couple of years prior to entering into the pandemic. And that's not a terrible proxy. And I think as we sit here today, I don't think any of our comments from previous calls have changed in terms of the restructuring market and our expectations for fiscal year 2022.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you. And thank you for taking my questions. Given the industry seeming inevitable transition away from ICE by the 2030 in Europe, at least, whether it's noise emissions or CO2 pollution. Do you see a risk that social acceptance of ICE will become increasingly challenging in the same way we have seen social acceptance of smoking fur [Phonetic] and precious skins change in the last two decades?
And picking up on comments you made around hydrogen and e-fuels. If we look at the main players in the auto industry today, the investment is being prioritized toward actually electric vehicles rather than by hydrogen or e-fuels. As a result, it seems reasonable to question what infrastructure will actually be support these technologies and who is going to make that investment? Can you see Ferrari investing in infrastructure to support that product and customers if you choose the technology part, which is differentiated from the main stream? Thank you.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, Dave.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, Ross.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. So, Jon, as I mentioned, the mix of securities that we're purchasing is very similar to the mix of our current portfolio. It'll be a little bit longer duration on the new mortgages purchased than the existing book obviously but similar duration on the munis, and so that will be a little lengthening, a little bit beyond sort of the five-year that you've seen from us historically but not much.
And with regard to what that would do in an up 200-rate shock, I don't have the immediate number at my hands but suffice it to say, with a five-year duration at 200 basis point shock is mathematically about a 10-point swing in value. That having been said, I'm not seeing anything in the 10-year yield profile or the forwards that would indicate that's a consensus view.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Raj.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, David, thanks for the question.
So, as I think about it, as we've talked about all the content being, I'll call it, accretive now on the tires and we think about adding more cash to use on repurchases, it will be a headwind as we think about cash flow next year. So, again, we're looking, I'll call it, to be in the $1 billion to $1.1 billion as a starting point. And that's taking into consideration the headwind that we'll see from the divestiture of the tires business.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I think you've got the handle on the numbers. I mean, we've got -- as we said in our script, we've got USD 200 million of cash in hand today. We're generating good cash flow from Gibraltar. Capex of Florence is relatively low, only 230 million.
So yeah, we think we're in a very strong position. We definitely have the ability to fund this project on our own and own it 100%. We are continuing discussions with a few select JV partners. We're going to see how those discussions play out.
We still think that the potential to maybe sell a minority stake at something based on NPV, right, $700 million or higher at today's prices. If we can do a very accretive transaction with a minority statement, then that's something we may consider doing. But if we don't get the valuation that we want, as you say, we have many other options to fund this and own it ourselves on a 100% basis. So we're in a much stronger position today, obviously.
And frankly, kind of looking back, we're glad that we didn't do a transaction last year because we're in a much stronger position today and have many more options. So sometimes it's the deals that you don't do that work out well for you.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. As I mentioned that's kind of a long-term goal over a few years and there are several reasons. A lot of the wins and a lot of the work that we're doing are on the next-generation tools in the litho space. And so those obviously have to go and get adopted and they have to ramp up on their own.
And also the wins -- the wins come in -- they come in chunks along the way. They don't come in one big movement of operations from -- into ours. So you see -- on any given quarter, you'll see several wins in certain sub modules and modules or components and those continue to kind of stack up on each other over time as well as the new tools really start to roll out as they introduce them to the market. That's the -- that's where we see kind of a slow general growth over the next several years and our target to get that space up to a reportable segment.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. Well, I think first and foremost shippers care about service because what we're talking about is getting their products to their clients. And so that's kind of a price of admission, and then they want to deal with partners that are easy to do business with. The more sophisticated definitely want to automate there is more and more API relationships and they want a fair price. So I think that having the technology and the capability are table stakes, but you also have to have a great service product. And if you can combine those two things it's a huge market and there is going to be all the freight if you want to grow the business.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, it's just based on current forwards. What I was trying to say is short rates are not going to move this year, and that's what the market is telling us, that's what the Fed is telling us. But we have seen a modest steepening of the yield curve in the last, call it, two months, and I would say market expectation is for a little bit more steepening, but it's relatively modest.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No question from that perspective, Nick. This is Chuck. We did have a really big fourth quarter as you know. We had a few pay off that we expected in the fourth quarter that leaked into the first quarter, so pass through higher than that than they normally are. Our markets -- our pipeline is -- was -- it was OK coming into the year but it's really strong right now. In the last 30 to 45 days we've seen a really big uptick in loan demand. We feel good about that, we've got a lot of construction products we need to fund over the summer, so I still feel like we'll end up in that mid-single digit growth rate for the year.
In Dennis' comments he mentioned our lines of credit based on the PPP funding and stimulus stuff got paid down a little over $20 million. If you kind of look at the numbers in our release, you'll see that our residential mortgages went down by another $11 million as we continue to refinance kind of some of the stuff on the books and it ends up being the gain on sale category. So we have a little pressure as far as loan on balance in the first quarter but we feel like we'll grow through that in the next three quarters.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi Salveen, its Steven. I'll answer your first question. So, in terms of the regulatory aspects of the ruxolitinib cream, obviously we cannot and do not speculate on what the FDA will or will not do, but we can tell you, we have tremendous confidence in the profile of the cream given now that we have four completed Phase 3 studies, two in atopic dermatitis, two in vitiligo. Including the long term follow up now for both safety and efficacy in these studies that demonstrates no new safety concerns related to what one would expect from any untoward systemic exposure.
The efficacy profile in atopic dermatitis that we have presented before in mild-to-moderate AD is outstanding and the safety profile isn't keeping with what I just said with a low systemic absorption of approximately 4% to 7% of bioavailability compared to an oral tablet. In other words, no untoward effects seen. So given all of that, we remain obviously extremely confident in the profile and we look forward to that PDUFA date on September 21. I will hand over the second part.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Sure. Happy to help now, first of all, I wouldn't-I characterize our performance as we think about the second quarter versus the first quarter as-or our performance in the quarter as borrowing from any other quarter. I mean, the quarter stands on its own. You saw the inventories were relatively flat in the second quarter relative to the first. But as you look at the sales growth from the first quarter, we did grow about 16%, a good percentage of that was really in pricing, majority that was in pricing and really favorable price across the board, really across all product lines. And we did have sort of low to mid single digit growth in volume as well, so that that gives you the primary drivers of the sequential performance from 1Q to 2Q.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So one of the things we're doing right now with independent agents and I think we referenced this a little bit earlier, is to actually make sure that the telematics program works for an independent agent. And so it will look different than the direct model. Where we may be pricing -- repricing midterm, we may be using now telematics data at renewal. We also have developed a product that allows consumers to really opt into telematics and we think that using that consumer experience both works well for an agent as well as works well for that agent's customer.
And that's really where we're starting to iterate on our product and develop a product that really does work for that channel.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Can we make that a little bit louder, please, Fred? We couldn't hear you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I would say, as I've said since 2016 in our first earnings call, the only competition we have in this market is ourselves. There is a whole host of players trying to do a whole host of different things. We're pursuing a vision of helping companies optimize every dollar that they spend, helping them see the business spend management vision that we have aligned with it and get incredible value in working with us and we are incredibly proud of what we've been able achieve for now thousands of customers in that area and we think it's a green light ahead to push us hard as we can and as thoughtfully as we can into building our way into this huge TAM that we're embarking on. So, nothing has changed and nothing is really concerning us around the ecosystem that they talked about.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. Good question. I'll just start with the second half of the question first. The 500,000 contemplates all Type-1, so Type-2 is an opportunity to actually grow on top of that. And I'll say that the -- we had talked in the past on these calls about data that we had collected. It was real-world data we had collected on the Type-2 community who are using Control-IQ and we had hoped to use that data to get the indication for our Type-2 product. In conversations that we've had with the FDA, we have learned now that we need to do -- we need to get additional clinical data. And as I mentioned just a moment ago, we're going to have to do a smaller study. It's going to start here in the next month or so. It will probably take us through later in this year to complete. And we will learn from that information and help us design the pivotal study. And the pivotal study will be run in 2022. So we're moving aggressively. Again, as I mentioned, Jordan Pinsker's bringing a lot of focus to our clinical organization and our clinical plans. And he's going to be driving this through Tandem for the next several years and we're looking forward to it. Thank you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good question. We really do think that Hoare Lea in the UK was the last major piece that we needed to add. We have a significant presence in the United States, primarily on the East and West Coast, we really do have one of the most elite high-end design practices and consulting practices and buildings, we've had in the company for about four years now, a large practice in Australia that services both the Australia, the New Zealand, and the Asia-Pacific region for us, but the area that we been significantly underrepresented was in the United Kingdom and Hoare Lea fills that in. We do think there are specialty niche areas that can be added with respect to some advance work on communications and low level lighting that we're a market leader, but we'll still be looking to add niche components, but we think that Hoare Lea fills out the geographic coverage that we're looking for as a corporation.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Eric, do you want to cover the macro and I could talk about the portfolio.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We'll get a few points, Jason.

    Prediction (one of UP, DOWN, SAME): SAME